Main Page

From My wiki
Jump to: navigation, search

[78] K. Hayashi, S. Wakino, K. Homma, N. Sugano, T. Saruta, "Pathophysiological significance of Ttype Ca2+ channels: function of T-type Ca2+ channels in renal microcirculation" J. Pharmacol Sci. vol. 99, no. three, pp. 221-227, Nov. 2005. [79] K. Hayashi, S. Wakino, N. Sugano, Y. Ozawa, K. Homma, T. Saruta, "Ca2+ channel subtypes and pharmacology inside the kidney" Circ. Res. vol. 100, no. 3, pp. 342-353, Feb. 2007. [80] C.B. Poulsen, R.H. Al-Mashhadi, L.L. Cribbs, O. Sk t, P.B. Hansen, "T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles" Kidney Int. vol. 79, no. 4, pp. 443-451, Feb. 2011. [81] M.G. Feng, M. Li, L.G. Navar, "T-type calcium channels in the regulation of afferent and efferent arterioles in rats" Am. J. Physiol. Renal. Physiol. vol. 286, no. 2, pp. F331-F337, Feb. 2004. [82] Y. Ozawa, K. Hayashi, T. Nagahama, K. Fujiwara, T. Saruta, "Effect of T-type selective calcium antagonist on renal microcirculation: research in the isolated perfused hydronephrotic kidney" Hypertension vol. 38, no. 3, pp. 343-7, Sep. 2001. 1940-0640-8-15 [83] Y. Abe Y, T. Komori, K. Miura, T. Takada, M. Imanishi, T. Okahara, K. Yamamoto, "Effects from the calcium antagonist http://usspire.com/members/whale4kendo/activity/638653/ nicardipine on renal function and renin release in dogs" J. Cardiovasc. Pharmacol. vol. five, no. two, pp. 254?59, Mar.Apr. 1983. [84] J.R. Dietz, J.O. Davis, R.H. Freeman, D. Villarreal, S.F. Echtenkamp, "Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs" Hypertension. vol five, no. 4, pp. 482?88, Jul.-Aug. 1983. [85] J. Heller, V. Horacek, "The impact of two unique calcium antagonists around the glomerular haemodynamics in dogs" Pflugers Arch. vol. 415, no. six, pp. 751?55, Mar. 1990. [86] M. Roy, G.P. Guthrie, F.P. Holladay, T.A. Kotchen, "Effects of verapamil on renin and aldosterone in the dog and rat" Am. J. Physiol. vol. 245, no. 4, pp. E410 416, Oct. 1983. [87] B.M. Brenner, E.V. Lawler, H.S. Mackenzie, "The hyperfiltration theory: a paradigm shift in nephrology" Kidney Int. vol. 49, no. six, pp. 1774-1777, Jun. 1996. [88] K. Hayashi, K. Homma, S. Wakino, H. Tokuyama, N. Sugano, T. Saruta, H. Itoh, "T-type Ca channel blockade as a determinant of kidney protection" Keio J. Med. vol. 59, no. three, pp. 84-95, 2010. [89] A. Derwa, P. Peeters, R. Vanholder, "Calcium channel blockers inside the prevention of end stage renal disease: a review" Acta Clin. Belg. vol. 59, no. 1, pp. 44-56, Jan-Feb. 2004. [90] Fujiwara K, Kanno Y, Hayashi K, Takenaka T, Saruta T., Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats. Clin. Exp. Hypertens. vol. 20, no. three, pp. 295-312, Apr. 1998.[91] T. Ishimitsu, T. Kameda, A. Akashiba, T. Takahashi, S. Ohta, M. Yoshii, J. Minami, H. Ono, A. Numabe, H. Matsuoka, "Efonidipine reduces proteinuria and plasma aldosterone in sufferers with chronic glomerulonephritis" Hypertens. Res. vol. 30, no. 7, pp. 621-626, Jul. 2007. [92] M. Kawabata, T. Ogawa, W.H. Han, T. Takabatake, "Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury" Clin. Exp. Pharmacol.